Loading clinical trials...

Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter | Clinical Trials | Clareo Health

COMPLETEDNA

Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter

Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter: a Multicenter, Randomized, Controlled Study

NCT06458101•Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

View on ClinicalTrials.gov

Summary

A prospective, multicenter, randomized, controlled clinical trial was conducted to compare the efficacy and safety of non-indwelling catheter and indwelling catheter in relieving postoperative catheter-related complications after ureteroscopic lithotripsy. By comparing the pain score and urination urgency score (PPIUS) of patients after ureteroscopic lithotripsy (including flexible ureteroscopy) lithotripsy to provide a reliable scientific basis for indwelling catheter after ureteroscopic lithotripsy.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with upper urinary tract calculi undergoing rigid ureteroscopic and soft ureteroscopic lithotripsy;
•Normal renal function;
•Aged between 18 and 70 years old
•Complete the operation under general anesthesia

Exclusion Criteria

•Solitary kidney;
•Previous history of renal transplantation or urinary diversion;
•Congenital malformation of urinary system;
•Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
•Severe heart or lung disease, Malignant tumor and immunodeficiency state
•Urethral stricture
•Neurogenic bladder
•Operation under epidural anesthesia or spinal anesthesia
•Large amount of bleeding during operation should be observed by indwelling catheter to observe urine color
•High risk factors such as large amount of pus fur should be observed during operation.
+2 more criteria

Locations (1)

Shanghai General Hospital

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

July 1, 2024

Primary Completion Date

June 30, 2025

Completion Date

June 30, 2025

Last Updated

November 19, 2025

Enrollment

180

ACTUAL participants

Conditions

UrolithiasisCatheter-related Bladder Discomfort

Interventions

Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

PROCEDURE

Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

PROCEDURE

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

NCT07275879

Ureteral Double-J StentUrolithiasis+1 more

View study

RECRUITINGPHASE1/PHASE2

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

NCT06158620

Post Operative PainUrolithiasis+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter

Inclusion Criteria

Exclusion Criteria

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Renal Stone Treatment Global Registry

Multiomics Biomarkers for Urolithiasis

Registry of MIUS for Urolithiasis (ReMIUS-U)

Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis